Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
Anticancer Research
|
May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour response
John Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 2, 2007
Molecular mechanisms of drug resistance in acute myeloid leukaemia
Donal P McLornan, Mary Frances McMullin, Patrick Johnston, et al.
Cancers
|
June 2, 2021
Therapeutics Targeting the Core Apoptotic Machinery
Claudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.
Cell Reports
|
November 21, 2023
cFLIP<sub>L</sub> acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes
Pavel Davidovich, Catherine A Higgins, Zaneta Najda, et al.
BMC Cancer
|
July 22, 2010
Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8
Alex D Chacko, Fabio Liberante, Ian Paul, et al.
The Journal of Pathology
|
August 15, 2018
Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition
Amy Mb McCorry, Maurice B Loughrey, Daniel B Longley, et al.
Cancer Research
|
October 6, 2005
Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer
Ultan McDermott, Daniel B Longley, Leeona Galligan, et al.
Cell Death & Disease
|
January 12, 2024
The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis
James Holloway, Aidan Seeley, Neville Cobbe, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells
Catherine Wilson, Timothy Wilson, Patrick G Johnston, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
May 4, 2021
Antibody therapy in pancreatic cancer: mAb-ye we're onto something?
Anna J Boland, Anthony A O'Kane, Richard Buick, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
Anticancer Research
|
May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour response
John Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 2, 2007
Molecular mechanisms of drug resistance in acute myeloid leukaemia
Donal P McLornan, Mary Frances McMullin, Patrick Johnston, et al.
Cancers
|
June 2, 2021
Therapeutics Targeting the Core Apoptotic Machinery
Claudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.
Cell Reports
|
November 21, 2023
cFLIP<sub>L</sub> acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes
Pavel Davidovich, Catherine A Higgins, Zaneta Najda, et al.
BMC Cancer
|
July 22, 2010
Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8
Alex D Chacko, Fabio Liberante, Ian Paul, et al.
The Journal of Pathology
|
August 15, 2018
Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition
Amy Mb McCorry, Maurice B Loughrey, Daniel B Longley, et al.
Cancer Research
|
October 6, 2005
Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer
Ultan McDermott, Daniel B Longley, Leeona Galligan, et al.
Cell Death & Disease
|
January 12, 2024
The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis
James Holloway, Aidan Seeley, Neville Cobbe, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells
Catherine Wilson, Timothy Wilson, Patrick G Johnston, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
May 4, 2021
Antibody therapy in pancreatic cancer: mAb-ye we're onto something?
Anna J Boland, Anthony A O'Kane, Richard Buick, et al.
Page
of 12